Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2 and HBB associated with haemoglobinopathies

  1. Stella Tamana
  2. Maria Xenophontos
  3. Anna Minaidou
  4. Coralea Stephanou
  5. Cornelis L Harteveld
  6. Celeste Bento
  7. Joanne Traeger-Synodinos
  8. Irene Fylaktou
  9. Norafiza Mohd Yasin
  10. Faidatul Syazlin Abdul Hamid
  11. Ezalia Esa
  12. Hashim Halim-Fikri
  13. Bin Alwi Zilfalil
  14. Andrea C Kakouri
  15. ClinGen Hemoglobinopathy VCEP
  16. Marina Kleanthous
  17. Petros Kountouris  Is a corresponding author
  1. Cyprus Institute of Neurology and Genetics, Cyprus
  2. Leiden University Medical Center, Netherlands
  3. Centro Hospitalar e Universitário de Coimbra, Portugal
  4. National and Kapodistrian University of Athens, Greece
  5. Ministry of Health Malaysia, Malaysia
  6. Universiti Sains Malaysia, Malaysia

Abstract

Haemoglobinopathies are the commonest monogenic diseases worldwide and are caused by variants in the globin gene clusters. With over 2400 variants detected to date, their interpretation using the ACMG/AMP guidelines is challenging and computational evidence can provide valuable input about their functional annotation. While many in silico predictors have already been developed, their performance varies for different genes and diseases. In this study, we evaluate 31 in silico predictors using a dataset of 1627 variants in HBA1, HBA2, and HBB. By varying the decision threshold for each tool, we analyse their performance (a) as binary classifiers of pathogenicity, and (b) by using different non-overlapping pathogenic and benign thresholds for their optimal use in the ACMG/AMP framework. Our results show that CADD, Eigen-PC, and REVEL are the overall top performers, with the former reaching moderate strength level for pathogenic prediction. Eigen-PC and REVEL achieve the highest accuracies for missense variants, while CADD is also a reliable predictor of non-missense variants. Moreover, SpliceAI is the top performing splicing predictor, reaching strong level of evidence, while GERP++ and phyloP are the most accurate conservation tools. This study provides evidence about the optimal use of computational tools in globin gene clusters under the ACMG/AMP framework.

Data availability

All data generated or analysed during this study are included in Supporting File 2 and Supporting File 3. Supporting File 2 provides the full dataset and subsets used as input in the analysis (sheet names starting with "Input") as well as the results of the analysis (sheets starting with "On"). Supporting File 3 includes the finetuning analysis for specific tools and data subsets, as described in the manuscript.We make the source code for evaluating the tools and generating the figures presented herein, freely available at https://github.com/cing-mgt/evaluation-of-in-silico-predictors.

Article and author information

Author details

  1. Stella Tamana

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  2. Maria Xenophontos

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5978-0193
  3. Anna Minaidou

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  4. Coralea Stephanou

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  5. Cornelis L Harteveld

    Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  6. Celeste Bento

    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
    Competing interests
    The authors declare that no competing interests exist.
  7. Joanne Traeger-Synodinos

    Laboratory of Medical Genetics, National and Kapodistrian University of Athens, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1860-5628
  8. Irene Fylaktou

    First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Norafiza Mohd Yasin

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  10. Faidatul Syazlin Abdul Hamid

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  11. Ezalia Esa

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  12. Hashim Halim-Fikri

    Malaysian Node of the Human Variome Project, Universiti Sains Malaysia, Kelantan, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  13. Bin Alwi Zilfalil

    Human Genome Centre, Universiti Sains Malaysia, Kelantan, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  14. Andrea C Kakouri

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  15. ClinGen Hemoglobinopathy VCEP

  16. Marina Kleanthous

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  17. Petros Kountouris

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    For correspondence
    petrosk@cing.ac.cy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2681-4355

Funding

Research and Innovation Foundation [Cyprus] (EXCELLENCE/1216/256)

  • Maria Xenophontos
  • Anna Minaidou
  • Bin Alwi Zilfalil
  • Marina Kleanthous
  • Petros Kountouris

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Tamana et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,105
    views
  • 161
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stella Tamana
  2. Maria Xenophontos
  3. Anna Minaidou
  4. Coralea Stephanou
  5. Cornelis L Harteveld
  6. Celeste Bento
  7. Joanne Traeger-Synodinos
  8. Irene Fylaktou
  9. Norafiza Mohd Yasin
  10. Faidatul Syazlin Abdul Hamid
  11. Ezalia Esa
  12. Hashim Halim-Fikri
  13. Bin Alwi Zilfalil
  14. Andrea C Kakouri
  15. ClinGen Hemoglobinopathy VCEP
  16. Marina Kleanthous
  17. Petros Kountouris
(2022)
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2 and HBB associated with haemoglobinopathies
eLife 11:e79713.
https://doi.org/10.7554/eLife.79713

Share this article

https://doi.org/10.7554/eLife.79713

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.

    1. Computational and Systems Biology
    Huiyong Cheng, Dawson Miller ... Qiuying Chen
    Research Article

    Mass spectrometry imaging (MSI) is a powerful technology used to define the spatial distribution and relative abundance of metabolites across tissue cryosections. While software packages exist for pixel-by-pixel individual metabolite and limited target pairs of ratio imaging, the research community lacks an easy computing and application tool that images any metabolite abundance ratio pairs. Importantly, recognition of correlated metabolite pairs may contribute to the discovery of unanticipated molecules in shared metabolic pathways. Here, we describe the development and implementation of an untargeted R package workflow for pixel-by-pixel ratio imaging of all metabolites detected in an MSI experiment. Considering untargeted MSI studies of murine brain and embryogenesis, we demonstrate that ratio imaging minimizes systematic data variation introduced by sample handling, markedly enhances spatial image contrast, and reveals previously unrecognized metabotype-distinct tissue regions. Furthermore, ratio imaging facilitates identification of novel regional biomarkers and provides anatomical information regarding spatial distribution of metabolite-linked biochemical pathways. The algorithm described herein is applicable to any MSI dataset containing spatial information for metabolites, peptides or proteins, offering a potent hypothesis generation tool to enhance knowledge obtained from current spatial metabolite profiling technologies.